The FDA is reviewing an application seeking expanded approval of an under-the-skin injection version of Leqembi (lecanemab).
Previously lecanemab was only approved as an SC injection for maintenance dosing, following an initial 18 month IV phase.
The new generic drug has been approved for treatment of bovine respiratory disease and associated pyrexia in beef and ...
FDA-approved oral GLP-1s match injectables in weight loss effectiveness with similar side effects and health benefits. There are differences, however.
New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...
Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection.
Operating under the FDA's 503B pathway, the Apex facility will prioritize the production of generic shortage-listed ...